Dr. Walker, the President and Chief Executive Officer of Aclaris Therapeutics, Inc., joined the Aldeyra board of directors in 2013. He is a board-certified dermatologist and serial entrepreneur with more than 22 years of experience in the biopharmaceutical and life science industries. Prior to founding Aclaris Therapeutics in 2012, he was co-founder, President and CEO of Vicept Therapeutics, Inc. (acquired by Allergan, Inc.). Dr. Walker has co-founded and led a number of life science companies including Octagon Research Solutions, Inc., a software and services provider to biopharmaceutical companies (acquired by Accenture plc); Trigenesis Therapeutics, Inc., a specialty dermatology company where he served as Chief Medical Officer (acquired by Dr. Reddy’s Laboratories Ltd); Cutix Inc., a commercial dermatology company. He began his pharmaceutical industry career at Johnson and Johnson, Inc. He co-founded and served on the board of directors of the annual Dermatology Summit, Dermatology Innovation Forum, and Advancing Innovation in Dermatology. Dr. Walker is on the board of directors of Aclaris Therapeutics Inc., a publicly held biotechnology company, as well as Life Sciences Pennsylvania and several private companies. In 2016, Dr. Walker was awarded the Frank Baldino Bioscience CEO of the Year award and the Ernst & Young Entrepreneur of the Year Greater Philadelphia award. He is also a Fellow of the American Academy of Dermatology. Dr. Walker received his M.B.A. from The Wharton School, University of Pennsylvania, his D.O. from Philadelphia College of Osteopathic Medicine and a B.A. in Biology from Lehigh University.